3DIcon to Pursue National Institute of Health Grant Request
Company Identifies Funding Opportunity to Apply 3D Imaging Technology to Medical Industry
TULSA, OK -- (Marketwired) -- 09/23/14 -- 3DIcon Corporation (PINKSHEETS: TDCP), a developer of groundbreaking 3D projection display technologies that are designed to produce full color, 360-degree volumetric high-resolution images, today announced that the Company will pursue a National Institute of Health (NIH) grant request for small businesses that support Biomedical Technology Development.
The Request for Proposal (RFP), published by NIH Guides and Contracts, seeks applicants past the proof of principal state who "intended to develop enabling technologies that could apply to the interests of most NIH institutes and Centers and range from basic biomedicine to research in all relevant organ systems and diseases."
3DIcon's planned title for the request -- "3D Volumetric Display of Neurological Data provided by MRI Imaging" -- will directly address volumetric imaging technologies, which provide capabilities to better position medical personnel during training, when diagnosing health problems, and before as well as during surgical procedures. The Company has secured a strong letter of support from a nationally recognized medical institution, which will be submitted as part of the grant request.
"As 3DIcon continues to develop its volumetric imaging technology, we are encouraged that organizations in the health industry, such as NIH, are providing resources and leadership for advancing medical technologies," said Victor Keen, CEO of 3DIcon. "We view the growing medical imaging market as aligning well with our strategic vision of identifying opportunities in industries that can best maximize and benefit from 3D capabilities."
Recent announcements in the tech industry, such as GE winning Food and Drug Administration approval for its new 3D breast imaging device, has brought significant attention to the capabilities and benefits for 3D technology over traditional 2D, which limits data and information for physician review. The 3D medical imaging market, previously forecasted to reach approximately $5.9 billion by 2017, has continued to grow due to advancements for applications such as MRIs, CT scans, and ultrasounds.
About 3DIcon Corporation
3DIcon Corporation (the "Company", "3DIcon", "we", "us" or "our") is a developer of projection 3D display technologies. The Company's patented volumetric 3D display technology, CSpace®, is being developed to produce 360-degree viewable, high-resolution, color images, and is intended for use in government and industrial applications such as air traffic control, medical imaging, automotive & aerospace design, geological visualization, weather visualization, battle space visualization, and cargo / baggage / people scan visualization. The Company also sells a software product, Pixel Precision®, a simple-to-use image creation / manipulation tool for engineers developing systems based on Texas Instruments' DLP® line of products. For more information please visit www.3dicon.net.
Source: 3DIcon Corporation
Released September 23, 2014